CRISPR-controlled proteases

Review (2024)
Author(s)

S.P.B. van Beljouw (Kavli institute of nanoscience Delft, TU Delft - BN/Stan Brouns Lab)

Stan J. J. Brouns (Kavli institute of nanoscience Delft, TU Delft - BN/Stan Brouns Lab)

Research Group
BN/Stan Brouns Lab
Copyright
© 2024 S.P.B. van Beljouw, S.J.J. Brouns
DOI related publication
https://doi.org/10.1042/BST20230962
More Info
expand_more
Publication Year
2024
Language
English
Copyright
© 2024 S.P.B. van Beljouw, S.J.J. Brouns
Related content
Research Group
BN/Stan Brouns Lab
Issue number
1
Volume number
52
Pages (from-to)
441-453
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

With the discovery of CRISPR-controlled proteases, CRISPR–Cas has moved beyond mere nucleic acid targeting into the territory of targeted protein cleavage. Here, we review the understanding of Craspase, the best-studied member of the growing CRISPR RNA-guided protease family. We recollect the original bioinformatic prediction and early experimental characterizations; evaluate some of the mechanistic structural intricacies and emerging biotechnology; discuss open questions and unexplained mysteries; and indicate future directions for the rapidly moving field of the CRISPR proteases.